8-127738294-A-G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP2BP4_StrongBS1_SupportingBS2

The NM_002467.6(MYC):​c.77A>G​(p.Asn26Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0319 in 1,610,196 control chromosomes in the GnomAD database, including 1,012 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.024 ( 72 hom., cov: 33)
Exomes 𝑓: 0.033 ( 940 hom. )

Consequence

MYC
NM_002467.6 missense

Scores

1
6
10

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2B:1

Conservation

PhyloP100: 5.19

Publications

99 publications found
Variant links:
Genes affected
MYC (HGNC:7553): (MYC proto-oncogene, bHLH transcription factor) This gene is a proto-oncogene and encodes a nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. The encoded protein forms a heterodimer with the related transcription factor MAX. This complex binds to the E box DNA consensus sequence and regulates the transcription of specific target genes. Amplification of this gene is frequently observed in numerous human cancers. Translocations involving this gene are associated with Burkitt lymphoma and multiple myeloma in human patients. There is evidence to show that translation initiates both from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site, resulting in the production of two isoforms with distinct N-termini. [provided by RefSeq, Aug 2017]
CASC11 (HGNC:48939): (cancer susceptibility 11)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 11 curated pathogenic missense variants (we use a threshold of 10). The gene has 2 curated benign missense variants. Gene score misZ: 1.2227 (below the threshold of 3.09). Trascript score misZ: 1.518 (below the threshold of 3.09). GenCC associations: The gene is linked to Burkitt lymphoma.
BP4
Computational evidence support a benign effect (MetaRNN=0.0082629025).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.024 (3648/152296) while in subpopulation NFE AF = 0.0363 (2466/68022). AF 95% confidence interval is 0.0351. There are 72 homozygotes in GnomAd4. There are 1653 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 72 Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYCNM_002467.6 linkc.77A>G p.Asn26Ser missense_variant Exon 2 of 3 ENST00000621592.8 NP_002458.2
MYCNM_001354870.1 linkc.74A>G p.Asn25Ser missense_variant Exon 2 of 3 NP_001341799.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYCENST00000621592.8 linkc.77A>G p.Asn26Ser missense_variant Exon 2 of 3 1 NM_002467.6 ENSP00000478887.2

Frequencies

GnomAD3 genomes
AF:
0.0240
AC:
3651
AN:
152178
Hom.:
72
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00707
Gnomad AMI
AF:
0.0351
Gnomad AMR
AF:
0.0282
Gnomad ASJ
AF:
0.0441
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00270
Gnomad FIN
AF:
0.0181
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0363
Gnomad OTH
AF:
0.0301
GnomAD2 exomes
AF:
0.0230
AC:
5750
AN:
249536
AF XY:
0.0231
show subpopulations
Gnomad AFR exome
AF:
0.00696
Gnomad AMR exome
AF:
0.0194
Gnomad ASJ exome
AF:
0.0427
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0174
Gnomad NFE exome
AF:
0.0344
Gnomad OTH exome
AF:
0.0289
GnomAD4 exome
AF:
0.0327
AC:
47736
AN:
1457900
Hom.:
940
Cov.:
32
AF XY:
0.0318
AC XY:
23053
AN XY:
724576
show subpopulations
African (AFR)
AF:
0.00683
AC:
228
AN:
33404
American (AMR)
AF:
0.0207
AC:
918
AN:
44430
Ashkenazi Jewish (ASJ)
AF:
0.0425
AC:
1104
AN:
25996
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39606
South Asian (SAS)
AF:
0.00392
AC:
337
AN:
85990
European-Finnish (FIN)
AF:
0.0160
AC:
855
AN:
53336
Middle Eastern (MID)
AF:
0.0165
AC:
95
AN:
5748
European-Non Finnish (NFE)
AF:
0.0383
AC:
42527
AN:
1109196
Other (OTH)
AF:
0.0278
AC:
1672
AN:
60194
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
2761
5522
8282
11043
13804
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1616
3232
4848
6464
8080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0240
AC:
3648
AN:
152296
Hom.:
72
Cov.:
33
AF XY:
0.0222
AC XY:
1653
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.00705
AC:
293
AN:
41568
American (AMR)
AF:
0.0282
AC:
431
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0441
AC:
153
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5172
South Asian (SAS)
AF:
0.00270
AC:
13
AN:
4818
European-Finnish (FIN)
AF:
0.0181
AC:
192
AN:
10624
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0363
AC:
2466
AN:
68022
Other (OTH)
AF:
0.0298
AC:
63
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
196
392
588
784
980
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0319
Hom.:
433
Bravo
AF:
0.0251
TwinsUK
AF:
0.0316
AC:
117
ALSPAC
AF:
0.0379
AC:
146
ESP6500AA
AF:
0.00794
AC:
35
ESP6500EA
AF:
0.0397
AC:
341
ExAC
AF:
0.0221
AC:
2686
Asia WGS
AF:
0.00404
AC:
15
AN:
3478
EpiCase
AF:
0.0380
EpiControl
AF:
0.0401

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Classic Hodgkin lymphoma Uncertain:1
Oct 01, 2021
Pathology Department, Puerta del Mar University Hospital
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

not provided Uncertain:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

MYC-related disorder Benign:1
Nov 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.60
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0
.;T;T;T;.;.
Eigen
Uncertain
0.52
Eigen_PC
Uncertain
0.52
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.71
T;T;T;T;T;T
MetaRNN
Benign
0.0083
T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
.;.;.;M;.;.
PhyloP100
5.2
PrimateAI
Uncertain
0.53
T
PROVEAN
Uncertain
-2.7
D;D;.;.;D;.
REVEL
Benign
0.23
Sift
Uncertain
0.018
D;D;.;.;D;.
Sift4G
Benign
0.081
T;D;D;T;D;D
Vest4
0.14
ClinPred
0.035
T
GERP RS
3.9
Varity_R
0.42
gMVP
0.50
Mutation Taster
=81/19
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4645959; hg19: chr8-128750540; COSMIC: COSV52371145; API